ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 Appropriate Use Criteria for #Coronary Revascularization in Patients With Stable #Ischemic Heart Disease
http://www.onlinejacc.org/content/early/2017/03/09/j.jacc.2017.02.001
As seen with the prior coronary revascularization AUC, revascularization in clinical scenarios with high symptom burden, high-risk features, and high coronary disease burden, as well as in patients receiving antianginal therapy, are deemed appropriate. Additionally, scenarios assessing the appropriateness of revascularization before kidney transplantation or transcatheter valve therapy are now rated. The primary objective of the AUC is to provide a framework for the assessment of practice patterns that will hopefully improve physician decision making.
http://www.onlinejacc.org/content/early/2017/03/09/j.jacc.2017.02.001
As seen with the prior coronary revascularization AUC, revascularization in clinical scenarios with high symptom burden, high-risk features, and high coronary disease burden, as well as in patients receiving antianginal therapy, are deemed appropriate. Additionally, scenarios assessing the appropriateness of revascularization before kidney transplantation or transcatheter valve therapy are now rated. The primary objective of the AUC is to provide a framework for the assessment of practice patterns that will hopefully improve physician decision making.
JACC: Journal of the American College of Cardiology
ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 Appropriate Use Criteria for Coronary Revascularization in Patients With Stable Ischemic…
Michael J. Wolk, MD, MACC, Moderator
Manesh R. Patel, MD, FACC, FAHA, FSCAI, Writing Group Liaison
Gregory J. Dehmer, MD, MACC, FSCAI, FAHA, Writing Group Liaison [∗][1]
Peter K. Smith, MD, FACC, Writing Group Liaison
James C. Blankenship, MD, MACC…
Manesh R. Patel, MD, FACC, FAHA, FSCAI, Writing Group Liaison
Gregory J. Dehmer, MD, MACC, FSCAI, FAHA, Writing Group Liaison [∗][1]
Peter K. Smith, MD, FACC, Writing Group Liaison
James C. Blankenship, MD, MACC…
#Defibrillators for Primary Prevention in Patients With #Ischemic or Nonischemic Cardiomyopathy: A Systematic Review and Meta-analysis
http://annals.org/aim/article/2633844/implantable-cardioverter-defibrillators-primary-prevention-patients-ischemic-nonischemic-cardiomyopathy-systematic
Implantable cardioverter-defibrillators (ICDs) have a role in preventing cardiac arrest in patients at risk for life-threatening ventricular arrhythmias.
Purpose:
To compare ICD therapy with conventional care for the primary prevention of death of various causes in adults with ischemic or nonischemic cardiomyopathy.
Conclusion:
Overall, primary prevention with ICD therapy versus conventional care reduced the incidence of sudden and all-cause death.
http://annals.org/aim/article/2633844/implantable-cardioverter-defibrillators-primary-prevention-patients-ischemic-nonischemic-cardiomyopathy-systematic
Implantable cardioverter-defibrillators (ICDs) have a role in preventing cardiac arrest in patients at risk for life-threatening ventricular arrhythmias.
Purpose:
To compare ICD therapy with conventional care for the primary prevention of death of various causes in adults with ischemic or nonischemic cardiomyopathy.
Conclusion:
Overall, primary prevention with ICD therapy versus conventional care reduced the incidence of sudden and all-cause death.
Prognostic and Practical Validation of ESC/EACTS High #Ischemic Risk Definition on Long-Term Thrombotic and Bleeding Events in Contemporary #PCI Patients
https://2medical.news/2021/06/16/prognostic-and-practical-validation-of-esc-eacts-high-ischemic-risk-definition-on-long-term-thrombotic-and-bleeding-events-in-contemporary-pci-patients/
https://2medical.news/2021/06/16/prognostic-and-practical-validation-of-esc-eacts-high-ischemic-risk-definition-on-long-term-thrombotic-and-bleeding-events-in-contemporary-pci-patients/
2Medical.News
Prognostic and Practical Validation of ESC/EACTS High #Ischemic Risk Definition on Long-Term Thrombotic and Bleeding Events in…
The ESC/EACTS myocardial revascularization guidelines recently standardized the definition of patients at high ischemic risk (HIR). However, the ability of ESC/EACTS-HIR criteria to stratify ischem…
Greater Adherence to Secondary Prevention Medications Improves Survival After #Stroke or Transient #Ischemic Attack: A Linked Registry Study
https://2medical.news/2021/08/01/greater-adherence-to-secondary-prevention-medications-improves-survival-after-stroke-or-transient-ischemic-attack-a-linked-registry-study/
https://2medical.news/2021/08/01/greater-adherence-to-secondary-prevention-medications-improves-survival-after-stroke-or-transient-ischemic-attack-a-linked-registry-study/
2Medical.News
Greater Adherence to Secondary Prevention Medications Improves Survival After #Stroke or Transient #Ischemic Attack: A Linked Registry…
Although a target of 80% medication adherence is commonly cited, it is unclear whether greater adherence improves survival after stroke or transient ischemic attack (TIA). We investigated associati…
Ankle‐Brachial Index and Subsequent Risk of Severe #Ischemic #Leg Outcomes: The ARIC Study
https://2medical.news/2021/11/06/ankle%E2%80%90brachial-index-and-subsequent-risk-of-severe-ischemic-leg-outcomes-the-aric-study/
https://2medical.news/2021/11/06/ankle%E2%80%90brachial-index-and-subsequent-risk-of-severe-ischemic-leg-outcomes-the-aric-study/
2Medical.News
Ankle‐Brachial Index and Subsequent Risk of Severe #Ischemic #Leg Outcomes: The ARIC Study
Ankle‐brachial index (ABI) is used to identify lower‐extremity peripheral artery disease (PAD). However, its association with severe ischemic leg outcomes (eg, amputation) has not been investigated…